IN2014MN01065A - - Google Patents

Info

Publication number
IN2014MN01065A
IN2014MN01065A IN1065MUN2014A IN2014MN01065A IN 2014MN01065 A IN2014MN01065 A IN 2014MN01065A IN 1065MUN2014 A IN1065MUN2014 A IN 1065MUN2014A IN 2014MN01065 A IN2014MN01065 A IN 2014MN01065A
Authority
IN
India
Prior art keywords
skin
ageing
composition
myricetin
glycoside
Prior art date
Application number
Other languages
English (en)
Inventor
Gail Jenkins
Silvina Beatriz Lotito
Jennifer Elizabeth Pople
Linda Jane Wainwright
Original Assignee
Unilever Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever Plc filed Critical Unilever Plc
Publication of IN2014MN01065A publication Critical patent/IN2014MN01065A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IN1065MUN2014 2011-12-06 2012-11-27 IN2014MN01065A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11192180 2011-12-06
PCT/EP2012/073697 WO2013083431A1 (fr) 2011-12-06 2012-11-27 Composition antivieillissement pour la peau

Publications (1)

Publication Number Publication Date
IN2014MN01065A true IN2014MN01065A (fr) 2015-05-01

Family

ID=47226185

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1065MUN2014 IN2014MN01065A (fr) 2011-12-06 2012-11-27

Country Status (9)

Country Link
US (1) US10406091B2 (fr)
EP (1) EP2788088B1 (fr)
CN (1) CN103957998B (fr)
AU (1) AU2012348700B2 (fr)
BR (1) BR112014013667A2 (fr)
CA (1) CA2857231A1 (fr)
IN (1) IN2014MN01065A (fr)
WO (1) WO2013083431A1 (fr)
ZA (1) ZA201403778B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103399151A (zh) * 2013-06-24 2013-11-20 上海交通大学医学院附属瑞金医院 Cxcl8细胞因子检测试剂在制备甲状腺乳头状癌的诊断试剂中的应用
US10456344B2 (en) * 2014-12-22 2019-10-29 Conopco, Inc. Hair composition
EP3397258A2 (fr) * 2015-12-30 2018-11-07 Consejo Nacional De Investigaciones Cientificas Y Tecnicas (CONICET) Utilisation d'analogues de brassinostéroïdes pour le traitement des affections dermiques par modulation des récepteurs hépatiques x (lxr) et traitements des maladies dermiques par des analogues de brassinostéroïdes agissant comme des modulateurs sélectifs des récepteurs hépatiques x (lxr)
JP6353939B1 (ja) * 2017-02-15 2018-07-04 横関油脂工業株式会社 油状組成物、その製法、油性基剤および皮膚外用剤
US11389392B2 (en) 2017-06-13 2022-07-19 Mary Kay Inc. Cosmetic compositions and methods for their use in firming skin
CN108420778A (zh) * 2018-06-17 2018-08-21 佛山市芊茹化妆品有限公司 一种具有美白功效的组合物及其应用
US20230414472A1 (en) * 2022-06-28 2023-12-28 Cosmax Inc. Cosmetic composition including garlic extract, black tea extract, and guava extract

Family Cites Families (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60120805A (ja) * 1983-11-30 1985-06-28 Akira Kitano 皮膚化粧料
FR2642305A1 (fr) * 1989-01-27 1990-08-03 Theramex Laboratoire Nouvelles compositions de dermo-cosmetologie et leur procede d'obtention
US6414037B1 (en) 1998-01-09 2002-07-02 Pharmascience Pharmaceutical formulations of resveratrol and methods of use thereof
AT407821B (de) 1998-03-24 2001-06-25 Franz Dr Stueckler Mittel auf der basis von naturstoffen
CN1195489C (zh) * 1999-01-12 2005-04-06 内蒙古宇航人化妆品有限责任公司 沙棘精华素
CZ20014004A3 (cs) * 1999-05-17 2002-05-15 The Procter & Gamble Company Způsoby kosmetické regulace stavu keratinové tkáně savců pomocí místního nanáąení fytosterolových kosmetických přípravků a tyto přípravky
JP2001039849A (ja) 1999-07-27 2001-02-13 Shiseido Co Ltd コラーゲン産生促進剤
US6555573B2 (en) 2000-12-21 2003-04-29 The Quigley Corporation Method and composition for the topical treatment of diabetic neuropathy
FR2820975B1 (fr) 2001-02-21 2004-03-12 Oreal Composition pour application topique comprenant au moins un hydroxystilbene et au moins un polyol pour solubiliser l'hydroxystilbene
WO2003030857A1 (fr) 2001-10-04 2003-04-17 Unilever Plc Renforcement du developpement de la barriere epidermique de la peau
EP1314420A1 (fr) * 2001-11-23 2003-05-28 Cognis Iberia, S.L. Compositions contre le vieillissement
EP1327438A1 (fr) * 2002-01-12 2003-07-16 Dr. Scheller Cosmetics AG Composition cosmetique et son application
US6579543B1 (en) 2002-02-22 2003-06-17 Jackie H. McClung Composition for topical application to skin
AU2003293977A1 (en) 2002-10-16 2004-05-04 L'oreal Cosmetic composition for preventing and/or correcting the functional disorders of the pilo-sebaceous unit of mammals
KR100600249B1 (ko) 2002-12-27 2007-04-12 주식회사한국신약 항산화 및 노화 억제 활성을 가지는 박태기나무 추출물 및이를 함유하는 항산화, 피부 노화 억제 및 주름 개선용화장료 조성물
AU2003303370A1 (en) * 2002-12-27 2004-07-22 Hankook Pharm. Co., Inc. Extract of cercis chinensis having anti-oxidant activity and anti-aging activity, and cosmetical composition containing the extract for anti-oxidation, skin-aging protection and wrinkle improvement
GB0311816D0 (en) 2003-05-22 2003-06-25 Unilever Plc Skin treatments
DE10329955A1 (de) * 2003-07-03 2005-02-03 Merck Patent Gmbh Verwendung eines hydroalkoholischen Extrakts aus Bauhinia zur Herstellung einer Zubereitung
US7320797B2 (en) 2003-08-29 2008-01-22 Bioderm Research Antiaging cosmetic delivery systems
US20050186171A1 (en) 2004-02-23 2005-08-25 Winick Bernyce A. Skin cream
US7455860B2 (en) 2004-08-11 2008-11-25 Laila Nutraceuticals Dietary supplement formulation for controlling inflammation and cancer
US20060078530A1 (en) 2004-10-12 2006-04-13 Liu Kay M Using high-density grapes to rejuvenate human skin
US20060110415A1 (en) 2004-11-22 2006-05-25 Bioderm Research Topical Delivery System for Cosmetic and Pharmaceutical Agents
WO2006105440A2 (fr) 2005-03-30 2006-10-05 Sirtris Pharmaceuticals, Inc. Nicotinamide riboside et analogues
CA2546464A1 (fr) 2005-05-04 2006-11-04 Richard Wachsberg Application sequentielle de formulations orales et topiques pour traiter les rides et autres dommages subis par la peau
US20070048246A1 (en) 2005-09-01 2007-03-01 Biophysica Research, Inc. Novel skin care compositions
WO2007029982A1 (fr) * 2005-09-08 2007-03-15 Amorepacific Corporation Composition d'une application a usage externe pour la peau anti-vieillissement
CN101365431A (zh) 2005-10-14 2009-02-11 帝斯曼知识产权资产管理有限公司 包含白藜芦醇的营养药物组合物的新颖用途
WO2007073765A1 (fr) 2005-12-28 2007-07-05 Marfarma Holding S.P.A. Sel de zinc de methylselenol et compositions le contenant
US20070190209A1 (en) 2006-02-10 2007-08-16 Mannatech, Inc. All natural multivitamin and multimineral dietary supplement formulations for enhanced absorption and biological utilization
JP4954564B2 (ja) * 2006-02-10 2012-06-20 一丸ファルコス株式会社 メイラード反応生成物であるタンパク質−還元糖架橋物質を分解する製剤
US20070225360A1 (en) 2006-03-22 2007-09-27 L'oreal Anti-aging composition containing phloretin
FR2898808B1 (fr) 2006-03-27 2008-05-02 Biotechmarine Soc Par Actions "principe actif cosmetique compose de ferrulate d'arginine et d'un extrait de microalgue et ses utilisations".
WO2007112996A2 (fr) 2006-03-31 2007-10-11 Dsm Ip Assets B.V. Nouvelle utilisation de composés et de combinaisons de composés pour améliorer l'aspect physique
JP2009539844A (ja) 2006-06-06 2009-11-19 マサチューセッツ・インスティテュート・オブ・テクノロジー Ｓｉｒｔ１およびｌｘｒのコレステロール制御複合体ならびに使用法
ITLO20060004A1 (it) 2006-08-08 2008-02-09 River Pharma Srl "lapille" e una nuova invenzione avente per oggetto una nuova combinazione chimica stabile per uso cosmetico e farmaceutico contenente come ingredienti attivi l'acido alfa-lipoico ed il dimetilsulfossido, in grado di migliorare l'assorbimento, la bio
US8435547B2 (en) 2006-08-30 2013-05-07 John P. Blass Cream for stimulating mitochondrial activity in the skin
US20080070883A1 (en) 2006-09-19 2008-03-20 Wyeth Use of LXR modulators for the prevention and treatment of skin aging
KR100883757B1 (ko) * 2007-03-12 2009-02-12 성균관대학교산학협력단 신경전달물질 배출을 조절하기 위한 폴리페놀 화합물
US20100210692A1 (en) 2007-03-28 2010-08-19 Farmer Stephen R Methods of treatment using sirt modulators and compositions containing sirt1 modulators
JP2008239576A (ja) 2007-03-28 2008-10-09 Koei Kogyo Kk ブドウの芽及び蔓から抽出したレスベラトロール類を含有する組成物
US7794758B2 (en) 2007-04-05 2010-09-14 Pmc Formulas, Inc. Compounds and methods for promoting cellular health and treatment of cancer
US20080254135A1 (en) 2007-04-10 2008-10-16 Marvin Heuer Resveratrol-containing compositions for general health and vitality
EP2155769B1 (fr) 2007-05-04 2012-06-27 Katholieke Universiteit Leuven KU Leuven Research & Development Protection contre la dégénérescence tissulaire
EP1992322A1 (fr) 2007-05-11 2008-11-19 Dr. Scheller Cosmetics AG Composition pour application percutanée
EP2005941A3 (fr) 2007-06-01 2009-04-01 Henkel AG & Co. KGaA Compositions rajeunissant les cellules
WO2009003798A1 (fr) 2007-07-05 2009-01-08 Unilever N.V. Composition alimentaire comprenant du trans-resvératrol et son utilisation pour réguler la pression sanguine
US20090028895A1 (en) 2007-07-27 2009-01-29 Smith Walter P Methods and compositions for reducing facial lines and wrinkles
US20090047309A1 (en) 2007-08-13 2009-02-19 Maes Daniel H Cosmetic methods and compositions for repairing human skin
JP5281645B2 (ja) 2007-09-08 2013-09-04 イーエルシー マネージメント エルエルシー フェルラ酸レスベラトロール化合物、それらの化合物を含有する組成物およびそれらの使用方法。
FR2923717B1 (fr) 2007-11-15 2015-01-16 Caudalie Compositions de derives polyphenoliques stilbeniques et leurs applications pour lutter contre les pathologies et le veillissement des organismes vivants
WO2009082511A1 (fr) 2007-12-20 2009-07-02 Elc Management Llc Procédés et compositions pour traiter la peau
WO2009089011A2 (fr) 2008-01-08 2009-07-16 Sirtris Pharmaceuticals, Inc. Formulations de resvératrol
US20090324705A1 (en) 2008-02-13 2009-12-31 Nina Vikhrieva Phytonutrient compositions for topical use
US8029830B2 (en) 2008-04-18 2011-10-04 Nuvocare Health Services Inc. Composition and method for promoting internal health and external appearance
PE20091928A1 (es) 2008-05-29 2009-12-31 Bristol Myers Squibb Co Tienopirimidinas hidroxisustituidas como antagonistas de receptor-1 de hormona concentradora de melanina no basicos
ES2316312B1 (es) 2008-06-20 2010-02-08 Ignacio Umbert Millet Composicion farmaceutica dermatologica para el tratamiento de patologias de inflamacion de la piel, tales como por ejemplo dermatitis, dermatitis atopica, vitiligo, alopecia areata, acne, psoriasis y prurito,y combinaciones de las mismas.
WO2010002586A2 (fr) 2008-06-30 2010-01-07 Elc Management Llc Compositions topiques contenant de l’isonicotinamide
GB0811992D0 (en) 2008-07-01 2008-08-06 Mithen Richard Treatment
CA2731242A1 (fr) 2008-07-24 2010-01-28 Paolo Sassone-Corsi Compositions et procedes se rapportant a la fonction sirt1
DE102008047362A1 (de) 2008-09-15 2010-04-15 Henkel Ag & Co. Kgaa Zusammensetzung zur Hautaufhellung
BRPI0914192A2 (pt) 2008-09-22 2015-11-03 Biochemics Inc distribuição transdérmica de fármaco usando um osmólito e agente vasoativo
US20110190242A1 (en) 2008-09-23 2011-08-04 Resolvyx Pharmaceuticals, Inc. Compositions and methods for the treatment of inflammatory disease
ES2349966B1 (es) 2008-10-30 2011-11-18 Ignacio Umbert Millet Formulaciones topicas para el tratamiento de verrugas.
FR2938765B1 (fr) 2008-11-26 2010-12-31 Isp Investments Inc Composition cosmetique et/ou pharmaceutique comprenant un hydrolysat de feuille de vigne (vitis vinifera l.) en tant que principe actif activateur des proteines sirt
WO2010090830A1 (fr) 2009-01-20 2010-08-12 Isis Pharmaceuticals, Inc. Modulation de l'expression de sirt1
US20100215781A1 (en) 2009-02-25 2010-08-26 Joar Opheim Therapeutic composition comprising omega-3 polyunsaturated fatty acid or derivative thereof, resveratrol and green tea
JP2010202617A (ja) 2009-03-05 2010-09-16 Kose Corp 一重項酸素消去剤およびこれを含有する皮膚外用剤ならびに化粧料
US20100233128A1 (en) 2009-03-13 2010-09-16 Mci Media Capital Inc. Natural Skin Products Containing Dairy and Processes
FR2949044B1 (fr) 2009-08-12 2021-05-07 Expanscience Lab Composition comprenant une fraction d'insaponifiable
ITMI20091940A1 (it) 2009-11-05 2011-05-06 Functional Point S R L Composizione comprendente resveratrolo e almeno un polifenolo del vino rosso e suoi usi.

Also Published As

Publication number Publication date
ZA201403778B (en) 2015-11-25
US20140295010A1 (en) 2014-10-02
BR112014013667A2 (pt) 2017-06-13
AU2012348700B2 (en) 2015-08-27
AU2012348700A1 (en) 2014-06-12
CA2857231A1 (fr) 2013-06-13
CN103957998B (zh) 2018-06-12
EP2788088B1 (fr) 2019-06-19
WO2013083431A1 (fr) 2013-06-13
CN103957998A (zh) 2014-07-30
US10406091B2 (en) 2019-09-10
EP2788088A1 (fr) 2014-10-15

Similar Documents

Publication Publication Date Title
IN2014MN01065A (fr)
IL290494A (en) Extracellular vesicle associated with molecules and its uses
MX355080B (es) Mejora de la apariencia de la piel con aumento en la intensidad cromatica de la piel.
SG11201604697TA (en) Membrane-penetrating peptides to enhance transfection and compositions and methods for using same
MX349544B (es) Extractos de maesa japonica y métodos de uso.
MX369822B (es) Composiciones para proporcionar una proteccion de filtro solar mejorada.
PH12015502405A1 (en) Methods and compositions for wound healing
HK1217453A1 (zh) 用於改善疤痕組織的外觀和形成的方法及組合物
WO2012092350A3 (fr) Peptides de szeto-schiller pour utilisation topique
GB2541318A (en) Use of undaria extract to reduce signs of skin aging
GB2541316A (en) Compositions and methods for reducing oxidative stress
GB201901812D0 (en) Improvements in or relating to fire-rated door sets
GB2541315A (en) Topical compositions for stimulating adipogenesis and lipogenesis to reduce the signs of skin aging
BR112015022265B8 (pt) Composições pigmentadas para tratamento da pele
BR112015022275B8 (pt) Composições pigmentadas para tratamento da pele
GB201217419D0 (en) Improvements in or relating to oromucosal apomorphine compositions
WO2012173383A3 (fr) Composition à usage externe pour l'épiderme, contenant en tant que principe actif du cryptotanshinone
GB2540319A (en) Topical composition including a combination of extracts for reducing signs of skin aging
GB2541317A (en) Methods of reducing signs of skin aging
GB2541576A (en) Methods of reducing signs of skin aging using a combination of extracts
MX2016013544A (es) Uso del extracto de bidens para reducir los signos de envejecimiento de la piel.
WO2014004178A3 (fr) Compositions comprenant des phénols substitués et application topique de celles-ci
HK1217459A1 (zh) 用於改善疤痕組織的外觀和形成的方法及組合物
IL224403A (en) Cosmetic product prevents skin aging
IL244543B (en) Substances to increase collagen and elastin production and topical preparations containing them